FDA guides pharma on explaining unapproved drugs to payors

June 3, 2026 12:55 PM EDTUpdated 01:06 PM FDA+ Ex­plain­ing un­ap­proved drugs to pay­ors: FDA of­fers phar­ma new guid­ance to avoid pit­falls Zachary Brennan Senior Editor Bio­phar­ma com­pa­nies prepar­ing to launch the next prac­tice-chang­ing block­busters want pay­ors to know what’s com­ing be­fore they ul­ti­mate­ly land an FDA ap­proval. The trick is … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER